查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1892805

美容医学市场机会、成长驱动因素、产业趋势分析及预测（2026-2035年）

Aesthetic Medicine Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 199 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025年全球美容医学市场价值为232亿美元，预计到2035年将以13.5%的复合年增长率增长至802亿美元。

美容医学市场 - IMG1

市场快速扩张的驱动因素包括消费者对美容治疗意识的提高、医疗美容设备技术的不断创新、肥胖率的上升以及对非侵入性疗法的日益青睐。美容医学专注于透过微创或非手术干预来改善外貌，解决皱纹、色素沉着、肤质、毛髮再生和体型雕塑等问题。肥胖症的日益普遍已成为推动市场发展的重要因素，因为人们寻求超越传统减肥方法的塑形和改善体型的方案。由于肥胖会影响健康和自尊，抽脂、腹部整形、体型雕塑和非侵入性减脂等治疗的需求正在激增。该领域结合了外科和非手术技术，旨在改善皮肤鬆弛、橘皮组织、疤痕、多余脂肪、多余毛髮和色素沉着等问题，从而提升外观和自信心。

市场范围
起始年份 2025
预测年份 2026-2035
起始值 232亿美元
预测值 802亿美元
复合年增长率 13.5%

2025年，外科手术市场规模达47亿美元，预计2035年将达166亿美元。这些手术为脸部年轻化、身体塑形、隆乳和隆鼻等问题提供全面的解决方案，为寻求显着改善外观的患者带来持久而显着的效果。

预计到2025年，能量型美容市场规模将达56亿美元。这类解决方案提供精准、非侵入性或微创的治疗，且恢復期极短。能量型设备利用雷射、射频、超音波和强烈脉衝光（IPL）等先进技术，可解决多种美容问题，包括皮肤再生、除毛、纹身去除和塑形。

预计到2024年，北美美容医学市场将占据39.5%的份额。该地区的成长得益于消费者意识的提高、先进技术的广泛应用以及文化上对外观的重视。庞大的消费群体对美容手术有着浓厚的兴趣，这推动了对外科手术和非手术疗法的需求。

目录

第一章：方法论与范围

第二章：执行概要

第三章：行业洞察

  • 产业生态系分析
  • 产业影响因素
    • 成长驱动因素
      • 提高人们对美容手术的认识
      • 与医疗美容设备相关的技术进步
      • 肥胖症盛行率不断上升
      • 非侵入性手术的普及率不断提高
    • 产业陷阱与挑战
      • 美容手术费用高昂
      • 缺乏报销机制和严格的监管环境
    • 市场机会
      • 人工智慧与数位科技的融合
  • 成长潜力分析
  • 监管环境
  • 技术进步
    • 当前技术趋势
    • 新兴技术
  • 供应链分析
  • 报销方案
  • 2025年定价分析
  • 未来市场趋势
  • 差距分析
  • 波特的分析
  • PESTEL 分析

第四章：竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 关键进展
    • 併购
    • 伙伴关係与合作
    • 新产品发布
    • 扩张计划

第五章：市场估算与预测：依类型划分，2022-2035年

  • 外科手术
  • 非手术治疗

第六章：市场估算与预测：依产品划分，2022-2035年

  • 基于能源
    • 雷射美容设备
    • 以射频为基础（RF）的美容设备
    • 以光线为基础的美容设备
    • 超音波美容设备
    • 其他能源产品
  • 非能源型
    • 肉毒桿菌毒素
    • 皮肤填充剂
    • 植入物
      • 脸部植入
      • 隆乳
      • 其他植入物
    • 其他非能源类产品

第七章：市场估计与预测：依性别划分，2022-2035年

  • 男性
    • 18岁及以下
    • 19-34岁
    • 35-50岁
    • 51-64岁
    • 65岁以上
  • 女性
    • 18岁及以下
    • 19-34岁
    • 35-50岁
    • 51-64岁
    • 65岁以上

第八章：市场估算与预测：依最终用途划分，2022-2035年

  • 医院
  • 门诊手术中心
  • 美容中心及医疗水疗中心
  • 皮肤科诊所
  • 首页设定

第九章：市场估计与预测：依地区划分，2022-2035年

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋

第十章：公司简介

  • Apax Partners
  • Boston Scientific Corporation
  • 博士伦健康公司
  • El.En. SpA
  • GC Aesthetics plc
  • Huadong Medicine Co., Ltd
  • Johnson & Johnson
  • Merz Pharma
  • Sciton, Inc.
  • SharpLight Technologies Inc
  • Sisram Medical Ltd
  • Vitruvian Partners LLP
简介目录
Product Code: 2687

The Global Aesthetic Medicine Market was valued at USD 23.2 billion in 2025 and is estimated to grow at a CAGR of 13.5% to reach USD 80.2 billion by 2035.

Aesthetic Medicine Market - IMG1

The market's rapid expansion is fueled by increasing consumer awareness of aesthetic treatments, continuous technological innovations in medical aesthetic devices, rising obesity rates, and a growing preference for non-invasive procedures. Aesthetic medicine focuses on enhancing physical appearance through minimally invasive or non-surgical interventions, addressing concerns such as wrinkles, pigmentation, skin texture, hair restoration, and body contouring. The growing prevalence of obesity has become a significant driver, as individuals seek solutions to reshape and refine their bodies beyond traditional weight-loss methods. With obesity affecting both health and self-esteem, demand for treatments like liposuction, tummy tucks, body contouring, and non-invasive fat reduction is surging. The field combines surgical and non-surgical techniques to correct skin laxity, cellulite, scars, excess fat, unwanted hair, and hyperpigmentation, aiming to improve both appearance and confidence.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$23.2 Billion
Forecast Value$80.2 Billion
CAGR13.5%

The surgical procedures segment reached USD 4.7 billion in 2025 and is projected to reach USD 16.6 billion by 2035. These procedures provide comprehensive solutions for concerns including facial rejuvenation, body contouring, breast augmentation, and rhinoplasty, offering long-lasting and transformative results for patients seeking significant changes in appearance.

The energy-based segment accounted for USD 5.6 billion in 2025. These solutions offer precise, non-invasive or minimally invasive treatments with minimal downtime. Utilizing advanced technologies such as lasers, radiofrequency, ultrasound, and intense pulsed light (IPL), energy-based devices address a variety of cosmetic concerns, including skin rejuvenation, hair removal, tattoo removal, and body contouring.

North America Aesthetic Medicine Market held a 39.5% share in 2024. Growth in the region is supported by heightened consumer awareness, widespread adoption of advanced technologies, and a cultural emphasis on physical appearance. A large population with significant interest in cosmetic procedures is driving demand for both surgical and non-surgical interventions.

Key players operating in the Global Aesthetic Medicine Market include Johnson & Johnson, Boston Scientific Corporation, Huadong Medicine Co., Ltd, GC Aesthetics plc, Apax Partners, SharpLight Technologies Inc., Sisram Medical Ltd, Bausch Health Companies Inc., Merz Pharma, Vitruvian Partners LLP, and El.En. S.p.A. Companies in the Global Aesthetic Medicine Market are strengthening their presence by investing in research and development to create innovative, minimally invasive devices with higher efficacy and lower recovery times. Strategic partnerships and collaborations with distributors and healthcare providers are enhancing market reach and patient access. Firms are also focusing on expanding into emerging regions, offering training programs for clinicians, and integrating digital solutions such as AI-assisted treatment planning. Sustainability initiatives, personalized treatment options, and product diversification are being used to differentiate offerings and build long-term brand loyalty, while targeted marketing campaigns raise consumer awareness and drive adoption of advanced aesthetic procedures.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Type trends
    • 2.2.3 Product trends
    • 2.2.4 Gender trends
    • 2.2.5 End use trends
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing awareness regarding aesthetic procedures
      • 3.2.1.2 Technological advancements associated with medical aesthetic devices
      • 3.2.1.3 Rising prevalence of obesity
      • 3.2.1.4 Increasing adoption of non-invasive procedures
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost associated with aesthetic procedures
      • 3.2.2.2 Lack of reimbursement and stringent regulatory scenario
    • 3.2.3 Market opportunities
      • 3.2.3.1 Integration of AI and digital technologies
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological advancements
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Supply chain analysis
  • 3.7 Reimbursement scenario
  • 3.8 Pricing analysis, 2025
  • 3.9 Future market trends
  • 3.10 Gap analysis
  • 3.11 Porter's analysis
  • 3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers and acquisitions
    • 4.6.2 Partnerships and collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Type, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Surgical procedures
  • 5.3 Non-surgical procedures

Chapter 6 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Energy-based
    • 6.2.1 Laser-based aesthetic device
    • 6.2.2 Radiofrequency (RF)-based aesthetic device
    • 6.2.3 Light-based aesthetic device
    • 6.2.4 Ultrasound aesthetic device
    • 6.2.5 Other energy-based products
  • 6.3 Non-energy-based
    • 6.3.1 Botulinum toxin
    • 6.3.2 Dermal fillers
    • 6.3.3 Implants
      • 6.3.3.1 Facial implants
      • 6.3.3.2 Breast implants
      • 6.3.3.3 Other implants
    • 6.3.4 Other non-energy-based products

Chapter 7 Market Estimates and Forecast, By Gender, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Male
    • 7.2.1 18 years and below
    • 7.2.2 19-34 years
    • 7.2.3 35-50 years
    • 7.2.4 51-64 years
    • 7.2.5 65 years and above
  • 7.3 Female
    • 7.3.1 18 years and below
    • 7.3.2 19-34 years
    • 7.3.3 35-50 years
    • 7.3.4 51-64 years
    • 7.3.5 65 years and above

Chapter 8 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Ambulatory surgical centers
  • 8.4 Beauty centers and medical spas
  • 8.5 Dermatology clinics
  • 8.6 Home settings

Chapter 9 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 India
    • 9.4.3 Japan
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Apax Partners
  • 10.2 Boston Scientific Corporation
  • 10.3 Bausch Health Companies Inc.
  • 10.4 El.En. S.p.A
  • 10.5 GC Aesthetics plc
  • 10.6 Huadong Medicine Co., Ltd
  • 10.7 Johnson & Johnson
  • 10.8 Merz Pharma
  • 10.9 Sciton, Inc.
  • 10.10 SharpLight Technologies Inc
  • 10.11 Sisram Medical Ltd
  • 10.12 Vitruvian Partners LLP